Ken Griffin Bio Restorative Therapies, Inc. Transaction History
Citadel Advisors LLC
- $559 Billion
- Q4 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Bio Restorative Therapies, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 21,481 shares of BRTX stock, worth $44,895. This represents 0.0% of its overall portfolio holdings.
Number of Shares
21,481Holding current value
$44,895% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding BRTX
# of Institutions
17Shares Held
282KCall Options Held
0Put Options Held
0-
Geode Capital Management, LLC Boston, MA54.7KShares$114,3680.0% of portfolio
-
Stone X Group Inc.50.1KShares$104,7090.0% of portfolio
-
Wealth Alliance Mellville, NY40KShares$83,6000.01% of portfolio
-
Morgan Stanley New York, NY27.5KShares$57,4740.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA20.5KShares$42,7860.0% of portfolio
About BioRestorative Therapies, Inc.
- Ticker BRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 3,650,030
- Market Cap $7.63M
- Description
- BioRestorative Therapies, Inc., a life sciences company, focuses on the development of regenerative medicine products and therapies using cell and tissue protocols primarily involving adult stem cells. The company's two core developmental programs relate to the treatment of disc/spine disease and metabolic disorders. Its disc/spine program (brtx...